IN THE MATTER OF * BEFORE THE

MARK D. NOAR, M.D. * MARYLAND STATE BOARD
Respondent * OF PHYSICIANS

LICENSE NUMBER: D36351 * CASE NUMBER: 7719-0080 B

* * x * * * * ® x * * * *

ORDER OF SUMMARY SUSPENSION OF LICENSE TO PRACTICE
MEDICINE

 

Disciplinary Panel B (“Panel B”) of the Maryland State Board of Physicians (the
“Board”) hereby SUMMARILY SUSPENDS Mark D. Noar M.D.’s (the
“Respondent”) license to practice medicine in the State of Maryland, License Number
D36351.

Panel B takes such action pursuant to its authority under Md. Code Ann., State
Gov’t ("State Gov't") § 10-226(c)(2) (2014 Repl. Vol. and 2018 Supp.), concluding that
the public health, safety or welfare imperatively requires emergency action. Panel B
bases its conclusion on the following investigative findings.

INVESTIGATIVE FINDINGS'

 

Panel A has obtained investigatory information that Respondent’s continued
practice of medicine poses a substantial likelihood or risk of serious harm to public health

safety and welfare as evidenced by the findings and conclusion of a comprehensive

' ‘The statements regarding Respondent’s conduct are intended to provide Respondent with notice of the
basis of the suspension. They are not intended as, and do not necessarily represent a complete description
of the evidence, either documentary or testimonial, to be offered against Respondent regarding this
matter.
assessment program (the Assessment Program”) which concluded that Respondent is
“unfit to practice medicine” until he completes a residential treatment program as
specified by the Program.’

Based on the investigatory information obtained by Panel B as summarized
above, and the specific instances described below, Panel B has reason to believe that the
following facts are true and that there is a substantial likelihood of a risk of serious harm
to the public health, safety, or welfare by Respondent.

IL Background of License

1. At all times relevant hereto, Respondent was, and is, licensed to practice
medicine in Maryland. Respondent was originally licensed to practice medicine in 1988
under license number D36351. He has continuously renewed his license. Respondent last
renewed his license in or about September 2017, which will expire on September 30,
2019.

2. Respondent owns a medical practice, “GI Microsurgery Institute, PA,” with
offices in Towson and Bel Air, Maryland.* Since approximately 1990, Respondent has
maintained an outpatient surgery center at the Towson location. Respondent employs
approximately 11 staff persons, including three endoscopy technicians, two nurses, a

nurse anesthetist, as well as other clinical staff and administrative staff.

> The name of the Assessment Program is confidential. Respondent is aware of the name of the
Assessment Program.

> Respondent is aware of the type of residential treatment program that has been recommended.

‘ Previously, Respondent’s practice was called Endoscopic Microsurgery Associates.

2
3. Respondent practices gastroenterology (“GI”) and hepatology.°
Respondent performs endoscopic procedures and does not do general surgery procedures.

4. Respondent holds privileges at four Maryland hospitals.

5. Respondent is not board-certified in any medical specialty. Respondent’s
self-designated practice areas are internal medicine and gastroenterology.

6. On January 11, 2016, Respondent entered a Consent Order with
Disciplinary Panel B for failure to meet standards of quality care in that he performed
unnecessary endoscopic retrograde cholangiopancreatographies (“ERCPs”), failed to
recognize the leak of a contrast dye during an ERCP, and failed to keep adequate medical
records, in violation of Md. Code Ann., Health Occ. §§ 14-404(a)(22) and (40),
respectively. Respondent was reprimanded and placed on probation for three years with
terms and conditions.

7. Respondent also holds active medical licenses in New Jersey and New
York.

8. On March 7, 2017, New York reprimanded Respondent, assessed a fine,
and placed Respondent on probation based on a reciprocal action.

9. On May 15, 2017, New Jersey reprimanded Respondent and placed
Respondent on probation based on a reciprocal action.

10. On January 4, 2019, Respondent entered into‘a Consent Order with Panel B

to resolve charges of unprofessional conduct in the practice of medicine, in violation of

> Hepatology is the branch of medicine that incorporates the study of liver, gallbladder, biliary tree, and
pancreas as well as management of their disorders.
Health Oce. § 14-404(a)(3)(ii), and violating a condition of the January 11, 2016 Consent
Order. Under the terms of the January 4, 2019 Consent Order, Respondent’s license was
suspended for 45 days, effective January 26, 2019, and he was required to enroll in and
comply with the Maryland Physician Rehabilitation Program. (“MPRP”). Respondent
was also placed on probation for two years and required to pay a fine of $15,000 within
two years.

11. On March 19, 2019, Panel B issued an Order Terminating Suspension and
Imposing Probation. This Order reiterated the requirement of probation for two years, and
the requirement that Respondent pay a fine of $15,000 within the two-year probationary
period. In addition, the Order required: that Respondent remain enrolled in and compliant
with MPRP; that he continued to utilize an independent EEOC (Equal Employment
Opportunity Commission)-approved training program; and that his performance of ERCP
procedures be subject to peer and or chart review.

Il. Complaint from MPRP

12. On January 25, 2019, Respondent enrolled in MPRP. After an intake
evaluation, Respondent was advised by MPRP that he needed to undergo a full
evaluation. MPRP approved the Assessment Program to evaluate Respondent to include
interviews, appropriate testing, and a specific examination.

13. On February 25 and 26, 2019, Respondent was seen for evaluation by the
Assessment Program. Respondent signed releases for collateral contact with MPRP, staff
in Respondent’s practice, a family member, and a prior treating individual. The

Assessment Program also reviewed the January 2019 Consent Order, correspondence

4
from Respondent’s counsel, the January 2015 Consent Order, and a July 2012 press
release regarding an EEOC verdict against Respondent’s practice.

14. On April 10, 2019, the Board received the completed evaluation from the
Assessment Program which states that Respondent “is unfit to return to practice” until he
completes a residential treatment program for certain boundary violations at a facility that
is acceptable to MPRP.

II. Further Information from MPRP

15. On April 15, 2019, Respondent, at the recommendation of MPRP,
Respondent signed a “Voluntary Practice Cessation Agreement”, which was accepted by
MPRP on April 18, 2019.

16. On April 17, 2019, Respondent notified MPRP that he has completely
ceased all activities in the practice of medicine in Maryland .

17. On April 22, 2019, Respondent informed MPRP that he was scheduled to
be admitted to a residential treatment program on April 29, 2019.

18. On April 29, 2019, Respondent admitted himself to a ninety-day out-of-
state treatment program in a residential facility which is acceptable to MPRP.

19. On May 1, 2019, MPRP notified the Board that the Respondent had
decided to leave the residential treatment program as of May 1, 2019, without being
properly discharged.

CONCLUSION OF LAW
Based upon the foregoing Investigative Findings, Disciplinary Panel B concludes

that the public health, safety, or welfare imperatively requires emergency action, and

5
that pursuant to Md. Code Ann., State Gov’t § 10-226(c)(2) and Md. Regs. Code

10.32.02.08B(7), Respondent's license is immediately suspended.

ORDER

It is, by the affirmative vote of a majority of the quorum of Panel B considering
this case:

ORDERED that pursuant to the authority vested in Panel B by Md. Code Ann.,
State Gov’t § 10-226(c)(2) and Md. Regs. Code 10.32.02.08B(7), Respondent’s medical
license, D36351, to practice as a physician in the State of Maryland be and is hereby
SUMMARILY SUSPENDED; and be it further

ORDERED that a post-deprivation hearing in accordance with Md. Regs. Code
10.32.02.08B(7)(c) and E on the Summary Suspension, in which Panel B will determine
whether the summary suspension will continue, has been scheduled for May 22, 2019, at
1:15 p.m., at the Maryland State Board of Physicians, 4201 Patterson Avenue, Baltimore,
Maryland 21215-0095; and be it further

ORDERED that after the SUMMARY SUSPENSION hearing held before Panel
B, Respondent, if dissatisfied with the result of the hearing, may request within ten (10)
days an evidentiary hearing, such hearing to be held within thirty (30) days of the request,
before an Administrative Law Judge at the Office of Administrative Hearings,
Administrative Law Building, 11101 Gilroy Road, Hunt Valley, Maryland 21031-1301;

and be it further
ORDERED that a copy of this Order of Summary Suspension shall be filed with
Panel B in accordance with Md. Code Ann., Health Occ. § 14-407 (2014 Repl. Vol. &
2018 Supp.); and be it further

ORDERED that this is an Order of Panel B, and, as such, is a PUBLIC
DOCUMENT. See Md. Code Ann., Health Occ. §§ 1-607, 14-411.1(b)(2) and Md.

Code Ann., Gen. Prov. § 4—333(b) 6).

eshojzoi4 W,
D

ate Christine A. Farrelly
Executive Director
Maryland State Board of Physicians

 
     
